Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

SHANGHAI, Dec. 31, 2025 /PRNewswire/ -- Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed on the Hong Kong Stock Exchange (HKEX). The listing marks...

ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly

ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly

- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D on core technologies, including expansion of indications for the Grabody platform SEOUL, South...

Beyfortus® (nirsevimab) now available in Malaysia to protect all infants against RSV disease

Beyfortus® (nirsevimab) now available in Malaysia to protect all infants against RSV disease

Beyfortus® (nirsevimab) is an available option designed to protect all infants – whether born full-term or pre-term, healthy or with underlying conditions – against respiratory syncytial virus (RSV), with proven high and sustained efficacy, a...

Exploring the Next Era of Cell & Gene Therapy with Nobel Laureate in London

Exploring the Next Era of Cell & Gene Therapy with Nobel Laureate in London

PISCATAWAY, N.J., Oct. 20, 2025 /PRNewswire/ -- London will become the global spotlight for cell and gene therapy (CGT) this November as Nobel Laureate, scientific leaders, biotech innovators, and top investors convene to chart the future of one of...

Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances

Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances

SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the...

The Department of Health - Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi

The Department of Health - Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi

On the sidelines of a high-level US visit focused on healthcare innovation ABU DHABI, UAE, June 19, 2025 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of...

Tencent Cloud Commits to Support European Companies' Global Competitiveness and Realise AI Ambitions

Tencent Cloud Commits to Support European Companies' Global Competitiveness and Realise AI Ambitions

PARIS, June 16, 2025 /PRNewswire/ -- At Viva Technology 2025, Europe's largest technology event, Tencent Cloud highlighted the accelerating shift among enterprises toward connected platforms and multi-cloud strategies, key enablers for unlocking the...

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 to Russia Company plans to export PCV13 vaccine components "We aim for the global PCV market with our 21-valent and...

Dupixent approved in Singapore as the first-ever biologic medicine for patients with COPD

Dupixent approved in Singapore as the first-ever biologic medicine for patients with COPD

Following recent approvals in the EU, US and China, the Singapore approval is based on two replicate phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also showed improvements in lung function and...

Sanofi and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program

Sanofi and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program

Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial assistance MONTREAL, April 25, 2025 /PRNewswire/ -- The World Federation of Hemophilia (WFH) and WFH USA, together with Sanofi,...

  • 1
  • 2
  • menu
    menu